EUVIMEDEUVIMED entdecken
Crossref

Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations

Juan Zeng iD, Li Li, Chi Sun, Shen Sheng, Yuhua Tan, Jian Chen, Fei Xia iD, Xianming Deng iD, Xin Xu iD

The Journal of Physical Chemistry B · 2025

DOI: 10.1021/acs.jpcb.5c01781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2025. Verfasst von Juan Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, Guangdong Medical University, Dongguan 523808, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Molecular Dynamics Simulation, Antineoplastic Agents, Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science Fund for Distinguished Young Scholars of Guangdong Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)Molecular Dynamics SimulationAntineoplastic AgentsDrug DiscoveryHumansMutationCell Line, TumorMolecular Docking Simulation

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • School of Biomedical Engineering, Guangdong Medical University, Dongguan 523808, China.
  • State-province Joint Engineering Laboratory of Targeted Drugs from Natural Products, School of Life Sciences, Faculty of Medicine and Life Sciences, Xiamen University, Xiamen, Fujian 361102, China.
  • Shanghai Engineering Research Center of Molecular herapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200062, China.
  • Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen University, Xiamen 361003, China.
  • State Key Laboratory of Porous Materials for Separation and Conversion, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, MOE Key Laboratory of Computational Physical Sciences, Department of Chemi…

ORCID-Profile: Juan Zeng, Fei Xia, Xianming Deng, Xin Xu

Förderung

  • National Key Research and Development Program of China
  • Science Fund for Distinguished Young Scholars of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Zeng, J., Li, L., Sun, C., Sheng, S., Tan, Y., Chen, J., Xia, F., Deng, X., & Xu, X. (2025). Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.5c01781

Vancouver

Zeng J, Li L, Sun C, Sheng S, Tan Y, Chen J, et al. Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations. The Journal of Physical Chemistry B. 2025. doi:10.1021/acs.jpcb.5c01781

BibTeX
@article{Zeng2025,
  author = {Zeng, Juan and Li, Li and Sun, Chi and Sheng, Shen and Tan, Yuhua and Chen, Jian and Xia, Fei and Deng, Xianming and Xu, Xin},
  title = {Structure-Based Discovery of Active Pan-KRas Inhibitors Targeting G12D Mutants by Enhanced Sampling Simulations},
  journal = {The Journal of Physical Chemistry B},
  year = {2025},
  doi = {10.1021/acs.jpcb.5c01781}
}
Kostenlos starten →